Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

27 ta ish

Ish: Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

    Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

    MaqolaTuberculosis Research and EpidemiologyEurosurveillance201315 iqtibos
    ABI

  2. Uzbekistan: health system review.

    Mohir Ahmedov, Ravshan Azimov, Zulkhumor Mutalova +3

    MaqolaHealthcare Systems and ReformsPubMed201413 iqtibos
    ABI

  3. Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

    Helen Cox, Stobdan Kalon, Sholpan Allamuratova +6

    Maqola200711 iqtibos
    ABI

  4. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

    Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane +15

    Maqola20207 iqtibos
    ABI

  5. Sarlavhasiz

    Boshqa6 iqtibos
    ABI

  6. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

    Catharina Boehme, Pamela Nabeta, Doris Hillemann +16

    Maqola20104 iqtibos
    ABI

  7. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +4

    Maqola20074 iqtibos
    ABI

  8. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

    Erik von Elm, Douglas G. Altman, Matthias Egger +3

    Maqola20143 iqtibos
    ABI

  9. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    MaqolaTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos
    ABI

  10. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Nell Gray +5

    MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 iqtibos
    ABI

  11. Tuberculosis control in prisons: current situation and research gaps

    Masoud Dara, Colleen Acosta, Natalie V. S. Vinkeles Melchers +8

    Sharh maqola20152 iqtibos
    ABI

  12. Tuberculosis, social determinants and co-morbidities (including HIV)

    Raquel Duarte, Knut Lönnroth, Cláudia Carvalho +4

    Sharh maqola20172 iqtibos
    ABI

  13. Challenges and Progress with Diagnosing Pulmonary Tuberculosis in Low- and Middle-Income Countries

    Anthony Harries, Ajay Kumar

    Sharh maqola20182 iqtibos
    ABI

  14. Xpert<sup>®</sup> MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

    Arnaud Trébucq, Donald A. Enarson, Chen‐Yuan Chiang +9

    Maqola20112 iqtibos
    ABI

  15. Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries

    Elisa Ardizzoni, Emmanuel Fajardo, Peter Saranchuk +5

    Maqola20152 iqtibos
    ABI

  16. Has the utilisation of Xpert <sup>®</sup> MTB/RIF in Manicaland Province, Zimbabwe, improved with new guidance on whom to test?

    A. Jokwiro, Collins Timire, Anthony Harries +5

    Maqola20182 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI